Alyson K Myers

Dr. Alyson K Myers

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 August 2020 in Journal of Diabetes Science and Technology
Verified
Journal Article
Closed access
PDF file
AMAlyson K Myers
Alyson K Myers
LPLubaina Presswala
Lubaina Presswala
ABAditya Bissoonauth
Aditya Bissoonauth
NGNeha Gulati
Neha Gulati
MZMeng Zhang
Meng Zhang
RPRenee Pekmezaris
Renee Pekmezaris
Non-Hispanic Black (NHB) and Hispanic/Latinx (H/L) patients bear a disproportionate burden of type 2 diabetes and associated complications. Regular visits to a primary care doctor or diabetes specialist are warranted to maintain glycemic control, but for a myriad of reasons disparity populations may have difficulties receiving diabetes care. We seek to determine the feasibility of telehealth added to care as usual and secondarily to improve health outcomes (hemoglobin A1c [HbA1c]) in NHB and H/L with uncontrolled type 2 diabetes managed with two or three noninsulin agents. Twenty-nine patients were randomized to monthly phone calls or weekly to biweekly telehealth visits. Feasibility outcomes were summarized descriptively for the telehealth arm. Differences scores for A1C level and surveys were computed between baseline and three months and compared across arms using a two-sample t test or Mann-Whitney U test. Patients in the telehealth arm completed a median of eight visits (IQR: 5, 8), and 53% of those in the telephone arm completed 100% of their calls. Change in HbA1c was greater for those in the telephone arm (–2.57 vs –2.07%, P = .70) but the mean baseline HbA1c was higher in the telephone group (11.1% vs 10.3%). Although the change in HbA1c was not statistically different across arms, it was clinically significant. Augmenting care as usual with telehealth provided by telephone or tablet can be of benefit in improving glycemic control in NHB and H/L with type 2 diabetes. Larger studies need to explore this further.

15 January 2019 in Ethnicity & Health
Verified
Journal Article
Closed access
TTTimothy Tong
Timothy Tong
AMAlyson K Myers
Alyson K Myers
ABAditya A. Bissoonauth
Aditya A. Bissoonauth
RPRenee Pekmezaris
Renee Pekmezaris
AKAndrzej Kozikowski
Andrzej Kozikowski
Objectives: Type 2 Diabetes Mellitus and its complications disproportionately affect non-Hispanic blacks and Hispanic/Latinos more than non-Hispanic whites. These disparities stem from complex interactions between biological, behavioral and socioeconomic factors. In recent years, telemedicine has been used to manage Type 2 Diabetes; however limited recruitment and retention of black and Hispanic/Latino patients into clinical trials exploring the use of telemedicine have necessitated the elucidation of their perceptions regarding participation in such trials. This study investigated patient-reported reasons for declining participation, prematurely terminating participation or demonstrating poor adherence to the study protocol in an ongoing randomized clinical trial, ‘Feasibility of Telehealth Management of Diabetes Mellitus type 2 (T2DM) in Black and Hispanic Minority Patients’. Design: Semi-structured interviews comprised of open-ended questions and prompts were conducted by telephone to gauge patients’ actual and perceived challenges to participating in the trial and using telemedicine to manage their diabetes. Data were collated with that of the original clinical trial and subsequently content analyzed for overarching themes and trends. Results: Eight semi-structured interviews were completed telephonically. Themes that emerged from analysis included disinterest (47%), inconvenience (33%), lack of perceived benefit (13%), lack of awareness of diabetes diagnosis (7%) and perceived lack of ability to fully participate in the study (7%). Conclusion: Adoption of telemedicine to help minority patients manage diabetes holds promise but is limited by patient factors such as disinterest, inconvenience and lack of perceived benefit. Greater awareness and understanding of these issues will be critical as we strive for greater health equity in disparity patients with uncontrolled diabetes.

29 May 2019 in Current Diabetes Reports
Verified
Journal Article
Closed access
PDF file
AAAnika Afroz-Hossain
Anika Afroz-Hossain
MDMakeda Dawkins
Makeda Dawkins
AMAlyson K Myers
Alyson K Myers

23 January 2021 in Journal of Diabetes
Verified
Journal Article
Open access
PDF file
AMAlyson K Myers
Alyson K Myers
TKTara S. Kim
Tara S. Kim
XZXu Zhu
Xu Zhu
YLYan Liu
Yan Liu
MQMichael Qiu
Michael Qiu
RPRenee Pekmezaris
Renee Pekmezaris
Background: Diabetes has been identified as a risk factor for intubation and mortality in patients with coronavirus disease 2019 (COVID‐19), caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2). We seek to examine the impact of clinical variables such as glycosylated hemoglobin (HbA1c) on mortality and need for intubation, as well as demographic variables such as age, sex, and race on persons with type 2 diabetes and COVID‐19.Methods: Analyses were conducted on 4413 patients with an International Classification of Diseases and Related Health Problems (ICD‐10) diagnosis of type 2 diabetes and COVID‐19. Survival analysis was conducted using Kaplan‐Meier curves and the log‐rank test to compare subgroup analyses.Results: In this multivariate analysis, male gender, older age, and hyperglycemia at admission were associated with increased mortality and intubation, but this was not seen for race, ethnicity, insurance type, or HbA1c. Based on Kaplan‐Meier analysis, having comorbid conditions such as hypertension, chronic kidney disease, and coronary artery disease was associated with a statistically significant increased risk of mortality.Conclusions: Glycemic levels at admission have a greater impact on health outcomes than HbA1c. Older men and those with comorbid disease are also at greater risk for mortality. Further longitudinal studies need to be done to evaluate the impact of COVID‐19 on type 2 diabetes.

26 June 2023 in Women's Health Reports
Verified
Journal Article
Open access
AMAlyson K Myers
Alyson K Myers
MWMyia Williams
Myia Williams
RPRenee Pekmezaris
Renee Pekmezaris
Introduction: The burden of microaggressions in the workplace is an ongoing stressor for female physicians in academic medicine. For female physicians of Color or of the Lesbian, Gay, Bisexual, Transgender, Queer, Intersex, Asexual community, this burden is even heavier due to the concept of intersectionality. The goal of this study is to assess frequency of microaggressions experienced by participants. In addition, to explore the associations between microaggression and individual outcomes, patient care practices and attitudes, and perception of pay/promotion equity. Methods: This was a cross-sectional analysis of female residents, fellows and attendings conducted from December 2020–January 2021 at Northwell Health across all specialties. One hundred seventeen participants replied to the study in REDCap. They completed questionnaires related to the topics of imposter phenomenon, microaggressions, gender identity salience, patient safety, patient care, counterproductive work behavior and pay and promotion equity. Results: A majority of the respondents were white (49.6%) and 15+ years out of medical school (43.6%). Around 84.6% of female physicians endorsed experiencing microaggressions. There were positive associations between microaggressions and imposter phenomenon as well as microaggressions and counterproductive work behavior. There was a negative association between microaggressions and pay equity or promotion. The small sample size did not allow for us to examine differences by race. Discussion: Although the number of female physicians continues to rise due to an uptick in female medical school enrollees, female physicians still must deal with the burden of microaggressions in the workplace. Conclusions: As a result, academic medical institutions must seek to create more supportive workplace for female physicians.

8 May 2024 in Endocrine Practice
Verified
Journal Article
Open access
SXShiming Xu
Shiming Xu
AHAzucena Herrera
Azucena Herrera
CSClyde Schechter
Clyde Schechter
HTHumera Tabassum
Humera Tabassum
JMJovan Milosavljevic
Jovan Milosavljevic
AMAlyson K Myers
Alyson K Myers
Objective: Diabetic foot ulcers (DFUs) are a leading cause of morbidity and mortality, which disproportionately impacts underserved populations. This study aimed to provide data regarding the rates and outcomes of amputation in patients admitted with DFU in our health system, which cares for an ethnically diverse and underserved population. Methods: This retrospective study examined the electronic medical records of adult patients hospitalized with DFU at 3 hospitals in our health system between June 1, 2016, and May 31, 2021. Results: Among 650 patients admitted with DFU, 88% self-identified as non-White race. Male sex (odds ratio [OR], 0.62), low body mass index (OR, 0.98), and history of smoking (OR, 1.45) were significantly associated with amputation during the study period. A higher erythrocyte sedimentation rate (OR, 1.01), C-reactive protein level (OR, 1.05), and white blood cell count (OR, 1.11) and low albumin level (OR, 0.41) were found to be significantly associated with amputation versus no amputation during admission. The amputation risk during the index admission for DFU was 44%. Conclusion: Our study identified a high DFU-related amputation risk (44%) among adult patients who were mostly Black and/or Hispanic. The significant risk factors associated with DFU amputation included male sex, low body mass index, smoking, and high levels inflammation or low levels of albumin during admission. Many of these patients required multidisciplinary care and intravenous antibiotic therapy, necessitating a longer length of stay and high readmission rate. (c) 2024 AACE. Published by Elsevier Inc. This is an open access article under the CC BY license (http:// creativecommons.org/licenses/by/4.0/).